Alpha Teknova, Inc. TKNO US Equity
$7.31
+0.09 (+1.25%)
USD · as of 2026-08-27 · marketstack
Alpha Teknova, Inc. (Nasdaq: TKNO), an SEC filer in In Vitro & In Vivo Diagnostic Substances, closed at $7.31, +1.2%, on 2026-08-27, with a market cap of $392M, a return on equity of -22.8%, a net margin of -42.6% and 3-year sales growth of -0.7%. Institutional ownership, earnings history and filed financials are on the tabs below.
Short interest· FINRA consolidated · settlement 2026-08-14
6 settlement cycles| Shares short | 1.6M |
| % of shares out | 3.0% |
| Days to cover | 5.0 |
| Δ vs 2026-07-31 | +6.6% |
bars = shares short · line = days to cover (own scale)
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.